SIRNAOMICS-B (02257) recommends adopting the Restricted Stock Unit Plan for 2026.

date
16:50 24/03/2026
avatar
GMT Eight
Sanofi-B (02257) announces that, on March 24, 2026, the Board of Directors decided to terminate the Restricted Share Units Plan for 2022 and adopt the Restricted Share Units Plan for 2026, subject to approval by shareholders at the upcoming Special General Meeting of the Company.
SIRNAOMICS-B (02257) issued an announcement on March 24, 2026, stating that the board of directors has decided to terminate the restricted share unit plan for 2022 and adopt a new restricted share unit plan for 2026. This decision will need to be approved by the shareholders at a special meeting to be held by the company.